Immunovant (IMVT) Earnings Date, Estimates & Call Transcripts → Biden FINISHED On June 13th? (From Paradigm Press) (Ad) Free IMVT Stock Alerts $30.48 +0.60 (+2.01%) (As of 05/14/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 27EstimatedActual EPS (Feb. 12) -$0.36 Beat By $0.07 Consensus EPS (Feb. 12) -$0.43 Get Immunovant Earnings AlertsEnter your email address below to receive the latest news and earnings results for IMVT and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueIMVT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IMVT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him Immunovant Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243($0.48)($0.42)($0.45)Q2 20245($0.49)($0.41)($0.45)Q3 20244($0.55)($0.45)($0.49)Q4 20244($0.46)($0.37)($0.43)FY 202416($1.98)($1.65)($1.82)Q1 20253($0.53)($0.41)($0.48)Q2 20253($0.53)($0.44)($0.49)Q3 20253($0.56)($0.47)($0.52)Q4 20253($0.60)($0.48)($0.53)FY 202512($2.22)($1.80)($2.02)Q1 20261($0.46)($0.46)($0.46)Q2 20261($0.46)($0.46)($0.46)Q3 20261($0.47)($0.47)($0.47)Q4 20261($0.52)($0.52)($0.52)FY 20264($1.91)($1.91)($1.91)IMVT Earnings Date and InformationImmunovant last released its earnings data on February 12th, 2024. The reported ($0.36) earnings per share for the quarter, beating the consensus estimate of ($0.43) by $0.07. Immunovant has generated ($1.84) earnings per share over the last year (($1.84) diluted earnings per share). Earnings for Immunovant are expected to decrease in the coming year, from ($1.70) to ($1.82) per share. Immunovant has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 27th, 2024 based off prior year's report dates.Read More Immunovant Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/27/2024Estimated)------- 2/12/2024Q4 2023($0.43)($0.36)+$0.07($0.36)--11/9/2023Q2 2024($0.45)($0.45)-($0.45)--8/10/2023Q1 2024($0.44)($0.47)($0.03)($0.37)--5/22/2023Q1 2023($0.41)($0.46)($0.05)($0.46)--2/3/2023Q3 2023($0.41)($0.49)($0.08)($0.49)--11/4/2022Q2 2023($0.41)($0.41)-($0.41)-- Get the Latest News and Ratings for IMVT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immunovant and its competitors with MarketBeat's FREE daily newsletter. 8/5/2022Q1 2023($0.40)($0.35)+$0.05($0.35)--6/8/2022Q4 2022($0.38)($0.41)($0.03)($0.41)--2/4/2022Q3 2022($0.34)($0.36)($0.02)($0.36)--11/5/2021Q3 2021($0.26)($0.35)($0.09)($0.35)--8/9/2021Q2 2021($0.31)($0.31)-($0.31)-- 5/31/2021Q1 2021($0.33)($0.29)+$0.04($0.29)-- Immunovant Earnings - Frequently Asked Questions When is Immunovant's earnings date? Immunovant has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 27th, 2024 based off last year's report dates. Learn more on IMVT's earnings history. Did Immunovant beat their earnings estimates last quarter? In the previous quarter, Immunovant (NASDAQ:IMVT) reported ($0.36) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.43) by $0.07. Learn more on analysts' earnings estimate vs. IMVT's actual earnings. How much profit does Immunovant generate each year? Immunovant (NASDAQ:IMVT) has a recorded net income of -$210.96 million. IMVT has generated -$1.84 earnings per share over the last four quarters. What is Immunovant's EPS forecast for next year? Immunovant's earnings are expected to decrease from ($1.70) per share to ($1.82) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Krystal Biotech Earnings Iovance Biotherapeutics Earnings CRISPR Therapeutics Earnings SpringWorks Therapeutics Earnings Halozyme Therapeutics Earnings Immunocore Earnings ImmunityBio Earnings Arcellx Earnings Utz Brands Earnings Twist Bioscience Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong Earnings This page (NASDAQ:IMVT) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunovant, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.